看见一个 Expert Review of Anticancer Therapy。你们前面用依维莫斯,血、肝肾功能还好。下一步是否考虑索拉非尼+依维莫斯。供你参考。
8 Z x% C* `! O8 y5 S/ q; G& ~4 E5 r: m6 H
, |! b& @$ b3 f/ R4 X8 Q8 S6 eCurrently available feasibility data for possible combination strategies.
$ P3 ?# ^, B! a/ W————————————————————————————————2 p9 J/ V# r" O! L2 g
Combination Feasibility according to preliminary data
' t) y. e& m: r, ?" a+ m$ m6 m——————————————————————————————————
! Q. F A2 c% J# \Bevacizumab + sorafenib Yes, reduced dose # |( C7 e: V, G
Bevacizumab + sunitinib† No
9 ?9 m3 r U& | zBevacizumab + temsirolimus Yes 6 W; @& Z. w& `
Bevacizumab + everolimus Yes
+ O7 V1 s! P& |7 K" Z1 V$ G2 a: wSorafenib + sunitinib ?
- [" T! T# D L7 H- S OSorafenib + temsirolimus Yes, reduced dose , a1 e: x% C; N
Sorafenib + everolimus Yes, reduced dose
* T$ o9 D8 C4 z3 E* ?+ I; ISunitinib + temsirolimus† No # c" U. G/ O* M+ K# p" U$ B
Sunitinib + everolimus ?
0 S& y8 K/ u) t7 D% W. aTemsirolimus + everolimus ? . F7 P: z" V- {9 L- T
————————————————————
; p) x# p5 i _( I9 T, Y3 o†Led to US FDA warning.
9 G1 l) E& d4 [2 V( N; O?: As yet unattempted combination./ i, D0 J0 m; N# I; @
|